Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)

November 6-7, 2017

Agenda

November 6, 2017

8:30 a.m.

Welcome and Opening Remarks
Catherine Spong, MD
8:35 a.m.

Review and Approval of Minutes from August
Catherine Spong, MD
8:40 a.m. Introduction of Task Force Members
9:15 a.m. Summary and Discussion of Work Products from Meeting 1
  • Identification of federal activities
  • Recommendations for coordination of and collaboration on research related to pregnant women and lactating women
  • Dissemination of research findings and information relevant to pregnant and lactating women to providers and the public
9:15 a.m. Scientific Research and Federal Activities on Drugs, Vaccines, Vitamins, and Other Supplements for Pregnant and Lactating Women (PDF - 1.2 MB)
Sarah Glavin, PhD
9:45 a.m. Discussion
10:00 a.m. Overview of Draft Section of Federal Activities for Secretary's Report (PDF - 554 KB)
Catherine Spong, MD
10:45 a.m. Discussion
11:15 a.m. BREAK
 11:30 a.m. Public Comment Period
12:15 p.m. LUNCH
1:30 p.m. Ethical Issues Surrounding the Inclusion of Pregnant Women and Lactating Women in Clinical Research
1:30 p.m. Overview of Pregnant Women in Research and Ethical Issues (PDF - 590 KB)
Amina White, MD
2:15 p.m. Discussion
2:30 p.m. BREAK
3:00 p.m. Panel: Federal and Local Requirements Related to Pregnant and Lactating Women Participating in Clinical Research
3:00 p.m. Brief Overview of Presentations
 
3:00 p.m.
 
3:10 p.m.
Consent requirements for both mother and father (PDF - 225 KB)
Anne Drapkin Lyerly, MD, MA
 
3:20 p.m.
IRB interpretation of 45 CFR 46 Subpart B (PDF - 67 KB)
Karim Calis, PharmD, MPH, FASHP, FCCP
 
3:30 p.m.
 
3:40 p.m.
Regulatory perspective (PDF - 247 KB)
Tamara Johnson, MD, MS
 
3:50 p.m.
Applicability to lactating women (PDF - 479 KB)
Victoria Pemberton, RNC, MS, CCRC
4:00 p.m. Panel Discussion
Moderator: Ruth Faden, PhD, MPH
  • Would the removal of pregnant women as a "vulnerable population" change research in this population?
  • Many comments on the proposed Common Rule revisions recommend that pregnant women not be considered a "vulnerable population" but instead be considered "medically complex." Should NIH or others supporting research in these populations impose additional ethical restrictions beyond the Common Rule?
  • How should the therapeutic benefit for the pregnant woman be weighed against risk to the fetus?
  • What is the role of spousal/paternal consent?
  • How do the ethics of conducting research with pregnant women change for lactating women, if at all?
4:30 p.m. Q&A and Open Public Discussion
4:50 p.m.

Recap of Meeting, Action Items, and Charge to Group
Catherine Spong, MD
5:00 p.m.

END OF DAY 1

 

 

November 7, 2017

8:30 a.m.

Recap of Day 1 and Outline and Goals for Day 2
Catherine Spong, MD
8:45 a.m. Panel: Inclusion of Pregnant Women and Lactating Women in Research
8:45 a.m. Brief Overview of Presentations
8:45 a.m.
 
8:55 a.m.
Reluctance related to liability (PDF - 797 KB)
Michael Greene, MD
 
9:05 a.m.
Reluctance in vaccine research (PDF - 504 KB)
Carleigh Krubiner, PhD
 
9:15 a.m.
Impact on lactating women (PDF - 1.46 MB)
Diane Spatz, PhD
9:25 a.m. Panel Discussion
Moderator: Marjorie Jenkins, MD, MEdHP, FACP
  • What methods may alleviate or alter this reluctance to include pregnant women in research?
  • How does lactation affect research?
  • How would full inclusion affect research?
10:00 a.m. Q&A and Open Public Discussion
10:30 a.m. BREAK
10:45 a.m. Panel: Ethical Issues of Specific Clinical Research Designs
10:45 a.m. Brief Overview of Presentations
10:45 a.m.
Observational studies and clinical trials (PDF - 34 KB)
Jeanne Sheffield, MD
 
10:55 a.m.
PK/PD studies (PDF - 698 KB)
Steve Caritis, MD
 
11:05 a.m.
Convenience studies (PDF - 68 KB)
Amina White, MD
 
11:15 a.m.
Issues of inclusion in clinical research (PDF - 438 KB)
James Griffin, PhD
11:25 a.m. Panel Discussion
Moderator: Andrew Bremer, MD, PhD
  • How has inclusion of other groups (pediatric, older populations) affected research design or study outcomes?
  • Do specific study designs have less ethical impact for pregnant or lactating women?
  • Does pregnancy or lactation provide new opportunities for research designs?
11:55 a.m. Q&A and Open Public Discussion
12:15 p.m. LUNCH
1:30 p.m. Panel: Researcher, Industry, and Research Participant Perspectives
1:30 p.m. Brief Overview of Presentations
1:30 p.m.
 
1:40 p.m.
 
1:50 p.m.
 
2:00 p.m.
2:10 p.m. Panel Discussion
Moderator: Linda Lipson, MA
  • Are there different approaches and/or concerns for research in pregnancy and lactation from the physician/scientist/researcher viewpoint, as compared with industry's?
  • How does the participant play a role in research for pregnant or lactating women?
  • Does the size or scope of industry affect interest in research for pregnant women and lactating women?
2:40 p.m. Q&A and Open Public Discussion
3:15 p.m. BREAK
3:30 p.m. Discussion of Key Points Related to Ethical Issues Surrounding the Inclusion of Pregnant Women and Lactating Women in Clinical Research
4:30 p.m.

Recap of Meeting, Action Items, and Charge to Group (PDF - 107 KB)
Catherine Spong, MD
5:00 p.m. END OF DAY 2, ADJOURN MEETING

Return to Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) main page.

top of page BACK TO TOP